Literature DB >> 19922742

Long-term management of depression: tips for adjusting the treatment plan as the patient's needs change.

Richard C Shelton1.   

Abstract

Depression is a difficult-to-treat condition. Most individuals with depression do not achieve remission with any single treatment, and, when they do achieve remission, the majority will have residual symptoms. Therefore, clinicians must be prepared to aggressively manage relapse and recurrence throughout all phases of treatment. The ultimate goals for the long-term treatment of depression are to (1) help the patient achieve remission, (2) keep the patient as asymptomatic as possible, and (3) manage risk factors for subsequent episodes. Psychotherapies and pharmacotherapies appear to have dissimilar mechanisms of action and produce different effects in depression; psychotherapy, particularly cognitive-behavioral therapy and behavioral activation therapy, may have more of a relapse prevention effect than pharmacotherapy. Because chronicity and recurrence are the rule rather than the exception, clinicians should choose treatments that have shown efficacy for protecting against future episodes. In addition, factors such as comorbidities and stressful life events increase the likelihood of depressive relapse; thus, these problems must be addressed to prevent a full relapse. By anticipating and adjusting treatment to meet patients' changing needs over time, clinicians can help them achieve and maintain remission from depression. Copyright 2009 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922742     DOI: 10.4088/JCP.8133su1c.05

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

Review 1.  A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression.

Authors:  Shawn M McClintock; Anna R Brandon; Mustafa M Husain; Robin B Jarrett
Journal:  J ECT       Date:  2011-09       Impact factor: 3.635

2.  The use of antidepressant drugs and the lifetime prevalence of major depressive disorders in Italy.

Authors:  Mauro Giovanni Carta; Eugenio Aguglia; Alberto Bocchetta; Matteo Balestrieri; Filippo Caraci; Massimo Casacchia; Liliana Dell'osso; Guido Di Sciascio; Filippo Drago; Carlo Faravelli; Maria Efisia Lecca; Maria Francesca Moro; Pier Luigi Morosini; Marcello Nardini; Gabriella Palumbo; Maria Carolina Hardoy
Journal:  Clin Pract Epidemiol Ment Health       Date:  2010-08-27

3.  A randomized controlled neurophysiological study of a chinese chan-based mind-body intervention in patients with major depressive disorder.

Authors:  Agnes S Chan; Yvonne M Y Han; Sophia L Sze; Queenie Y Wong; Mei-Chun Cheung
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-30       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.